Next Article in Journal
Relationship between the Tokyo Guidelines and Pathological Severity in Acute Cholecystitis
Previous Article in Journal
SARS-CoV-2 Infection, Vaccination and Risk of Death in People with An Oncological Disease in Northeast Italy
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
JPM
Volume 13
Issue 9
10.3390/jpm13091334
Review Report
jpm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Article
Peer-Review Record

In Systemic Sclerosis Patients, Peripheral Blood CD21low B Cells and Serum IL-4 and IL-21 Influence Joint Involvement

J. Pers. Med. 2023, 13(9), 1334; https://doi.org/10.3390/jpm13091334
by Chiara Pellicano 1, Amalia Colalillo 1, Valeria Carnazzo 2, Serena Redi 2, Valerio Basile 3, Mariapaola Marino 4, Umberto Basile 2,*,† and Edoardo Rosato 1,†
Reviewer 1:
Richard Stratton
Reviewer 2:
Péter Németh
J. Pers. Med. 2023, 13(9), 1334; https://doi.org/10.3390/jpm13091334
Submission received: 9 August 2023 / Revised: 24 August 2023 / Accepted: 28 August 2023 / Published: 30 August 2023
(This article belongs to the Section Disease Biomarker)

Round 1

Reviewer 1 Report

Thank you for this interesting paper which addresses arthritis in SSc patients, an area of unmet need. 

Can the authors please add to the Table 1 the previous immunomodulatory treatments received.

Can the authors add a schematic diagram of the proposed pathways linking CD21low B cells to elevation of IL-4 and IL21 leading to joint damage.

 

 

 

 

 

Generally the English is clear. There are a few grammatical/translational errors that could be corrected at the stage of final editing by the Journal. 

Author Response

Reviewer #1

Thank you for this interesting paper which addresses arthritis in SSc patients, an area of unmet need.

Authors' Reply: We thank the reviewer for his/her comment.

 

Can the authors please add to the Table 1 the previous immunomodulatory treatments received.

Authors' Reply: We thank the reviewer for his/her suggestion to improve the quality of our manuscript and we modified table 1 accordingly.

 

Can the authors add a schematic diagram of the proposed pathways linking CD21low B cells to elevation of IL-4 and IL21 leading to joint damage.

Authors' Reply: We thank the reviewer for his/her suggestion to improve the quality of our manuscript and we added a schematic diagram of the proposed pathways linking elevation of IL-4, IL-21 and CD21low B cells leading to joint damage as a graphical abstract.

 

Reviewer 2 Report

The initial arthritis of early SSc patients is a not evident clinical symptom. The present paper well demonstrates the role of elevated level of CD21low B cells in relationship with IL-4 and IL-21. The statistical analysis of flow cytometric and immunoserologic data is appropriate and it is the main strength of the work. The interpretation and discussion of the results is relevant. It would be interesting to analyze the following correlations with IL-10 and TGF-beta to better understand the pathologic mechanism.  

Author Response

Reviewer #2

The initial arthritis of early SSc patients is a not evident clinical symptom. The present paper well demonstrates the role of elevated level of CD21low B cells in relationship with IL-4 and IL-21. The statistical analysis of flow cytometric and immunoserologic data is appropriate and it is the main strength of the work. The interpretation and discussion of the results is relevant.

Authors' Reply: We thank the reviewer for his/her comment.

It would be interesting to analyze the following correlations with IL-10 and TGF-beta to better understand the pathologic mechanism. 

Back to TopTop